O-024Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)
Siena, S, Demetri, G, Doebele, R, Chae, Y, Conkling, P, Garrido-Laguna, I, Garrido, P, Rolfo, C, Sigal, D, Eng, S, Simmons, B, Ye, C, Ciardiello, FVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz154.023
Date:
July, 2019
File:
PDF, 80 KB
2019
File converter
More search results
More benefits 
